Background Clostridium difficile is a leading cause of morbidity and mortality in several
countries. However, there are limited evidence characterizing its role as a global public …

In the last three decades, Clostridium difficile infection (CDI) has increased in incidence and
severity in many countries worldwide. The increase in CDI incidence has been particularly …

Clostridium difficile infections (CDI) are associated with decreased survival, and up to 30%
of CDI patients may experience a recurrence. Data on the impact of recurrent CDI on …

Background Clostridium difficile infection (CDI) is the most common healthcare associated
infection and is highly prevalent in Europe and North America. Limited data is available on …

We assessed the efficacy and safety of fidaxomicin, a narrow-spectrum macrocyclic
antibiotic, for treating inpatients with Clostridioides (Clostridium) difficile infection (CDI) in …

Clostridioides (Clostridium) difficile is the leading cause of healthcare-associated infectious
diarrhea in the developed world. Retrospective studies have shown a lower incidence of C …

Background Clostridium difficile infection (CDI) is a public health threat and associated with
significant mortality. However, there is a paucity of objectively derived CDI severity scoring …

Background Clostridium difficile is the leading cause of health care–associated infections.
Given the high incidence of C. difficile infection (CDI) and the lack of primary prevention …

To increase understanding of the epidemiology, risks, consequences and resource
utilization of Clostridium difficile infection (CDI) in Japan, a systematic literature review was …

Objectives Clostridioides difficile is an important pathogen of healthcare-associated
gastrointestinal infections. Recently, an increased number of C. difficile infection (CDI) …